ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1164508
BOSTON, MA
Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$7,705,209
+$6,929,401 QoQ
Shares Held
972,880
+627.3% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 238 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $921,160,135 across 28 Drug Manufacturers - Specialty & Generic names. XERS ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,137,442 | $225,456,582 | |
| 2 | VTRS |
Viatris Inc
|
8,371,218 | $132,934,941 | |
| 3 | HLN |
Haleon plc
|
14,181,817 | $132,316,352 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,642,086 | $67,374,788 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
957,514 | $61,233,020 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
3,732,924 | $59,838,771 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
562,016 | $46,523,684 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
1,872,157 | $46,073,783 |
All Filings in XERS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,705,209 | 972,880 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $775,808 | 133,760 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,686,070 | 214,786 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||